Our lab has developed a DNA vector, pR-NEO, and methods which allow the reproducible stable introduction of this DNA into the human parasite Leishmania major following selection with the aminoglycoside G418, a process termed transfection. Preliminary data show that this DNA exists extra-chromosomally, replicates, expresses a correctly processed mRNA bearing the mini-exon sequence attached to a hybrid gene in which the coding region of the normal DHFR-TS mRNA is replaced by the coding region of neomycin phosphotransferase gene, and expresses this enzyme at a level sufficient to confer resistance to the drug G418 (an aminoglycoside related to neomycin). These features permit the isolation of transfected cells, in liquid culture of on plates. Moreover, this plasmid construct can increase in copy number in response to increased drug pressure, and can be reisolated from the transfected Leishmania and reintroduced into E. coli for further analysis. These findings allow us to propose to use this DNA to initiate functional genetic studies of Leishmania. Four basic areas of experimentation are proposed: 1) optimization and further development of the methods of transfection, including the development of transient assays. 2) analysis of the fate and structure of the transfected DNAs, and the structure and processing of hybrid RNAs encoded therein. 3) dissection of the pR-NEO vector in an effort to delineate minimal genetic elements such as origins, promoters, processing sites and elements conferring faithful segregation. Attention will be given to testing current molecular models such as the occurrence of poly-cistronic pre-mRNAs expressed from a distant 5' promoter. 4) manipulation of the pR-NEO vector in a way that will allow the expression of passenger DNA molecules, such as cDNAs or genomic DNA segments. This approach may ultimately permit the isolation and functional testing of other Leishmania genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029646-03
Application #
3144516
Study Section
Tropical Medicine and Parasitology Study Section (TMP)
Project Start
1990-03-01
Project End
1995-02-28
Budget Start
1992-03-01
Budget End
1993-02-28
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Grybchuk, Danyil; Akopyants, Natalia S; Kostygov, Alexei Y et al. (2018) Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite Leishmania. Proc Natl Acad Sci U S A 115:E506-E515
Kohl, Kid; Zangger, Haroun; Rossi, Matteo et al. (2018) Importance of polyphosphate in the Leishmania life cycle. Microb Cell 5:371-384
Hartley, Mary-Anne; Eren, Remzi O; Rossi, Matteo et al. (2018) Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1?. Microb Cell 5:137-149
Robinson, John I; Beverley, Stephen M (2018) Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase. J Biol Chem 293:6460-6469
Brettmann, Erin A; Lye, Lon-Fye; Beverley, Stephen M (2018) Spontaneous excision and facilitated recovery as a control for phenotypes arising from RNA interference and other dominant transgenes. Mol Biochem Parasitol 220:42-45
Eren, Remzi Onur; Kopelyanskiy, Dmitry; Moreau, Dimitri et al. (2018) Development of a semi-automated image-based high-throughput drug screening system. Front Biosci (Elite Ed) 10:242-253
Davenport, Bennett J; Martin, Casey G; Beverley, Stephen M et al. (2018) SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice. PLoS Negl Trop Dis 12:e0006921
Iantorno, Stefano A; Durrant, Caroline; Khan, Asis et al. (2017) Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage. MBio 8:
Kuhlmann, F Matthew; Robinson, John I; Bluemling, Gregory R et al. (2017) Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor. Proc Natl Acad Sci U S A 114:E811-E819
Castiglioni, Patrik; Hartley, Mary-Anne; Rossi, Matteo et al. (2017) Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid. PLoS Negl Trop Dis 11:e0005240

Showing the most recent 10 out of 104 publications